Blume Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.4M | Sell |
45,083
-7,611
| -14% | -$1.77M | 1.67% | 19 |
|
|
2026
Q1 | $12.9M | Sell |
52,694
-13,964
| -21% | -$3.25M | 2.19% | 15 |
|
|
2025
Q4 | $13.8M | Sell |
66,658
-511
| -0.8% | -$101K | 2.51% | 10 |
|
|
2025
Q3 | $12.5M | Sell |
67,169
-123
| -0.2% | -$21.1K | 2.37% | 12 |
|
|
2025
Q2 | $10.3M | Sell |
67,292
-51
| -0.1% | -$7.84K | 2.07% | 18 |
|
|
2025
Q1 | $11.2M | Sell |
67,343
-465
| -0.7% | -$72.8K | 2.5% | 10 |
|
|
2024
Q4 | $9.81M | Buy |
67,808
+2,777
| +4% | +$430K | 2.2% | 16 |
|
|
2024
Q3 | $10.5M | Sell |
65,031
-128
| -0.2% | -$20.4K | 2.36% | 13 |
|
|
2024
Q2 | $9.52M | Buy |
65,159
+5,894
| +10% | +$877K | 2.3% | 13 |
|
|
2024
Q1 | $9.38M | Buy |
59,265
+1,500
| +3% | +$239K | 2.26% | 17 |
|
|
2023
Q4 | $9.05M | Buy |
57,765
+992
| +2% | +$152K | 2.37% | 13 |
|
|
2023
Q3 | $8.84M | Sell |
56,773
-738
| -1% | -$122K | 2.62% | 10 |
|
|
2023
Q2 | $9.52M | Buy |
57,511
+5,938
| +12% | +$958K | 2.79% | 10 |
|
|
2023
Q1 | $7.99M | Buy |
51,573
+7,493
| +17% | +$1.21M | 2.53% | 11 |
|
|
2022
Q4 | $7.79M | Sell |
44,080
-700
| -2% | -$121K | 2.63% | 8 |
|
|
2022
Q3 | $7.32M | Sell |
44,780
-242
| -0.5% | -$41K | 2.76% | 11 |
|
|
2022
Q2 | $7.99M | Sell |
45,022
-10,994
| -20% | -$1.96M | 3.16% | 8 |
|
|
2022
Q1 | $9.93M | Sell |
56,016
-502
| -0.9% | -$85.4K | 3.27% | 8 |
|
|
2021
Q4 | $9.67M | Buy |
56,518
+686
| +1% | +$112K | 3.19% | 10 |
|
|
2021
Q3 | $9.02M | Sell |
55,832
-245
| -0.4% | -$41.8K | 3.3% | 10 |
|
|
2021
Q2 | $9.24M | Buy |
56,077
+2,127
| +4% | +$352K | 3.38% | 9 |
|
|
2021
Q1 | $8.87M | Buy |
53,950
+1,586
| +3% | +$257K | 3.49% | 9 |
|
|
2020
Q4 | $8.24M | Sell |
52,364
-793
| -1% | -$117K | 3.53% | 8 |
|
|
2020
Q3 | $7.91M | Sell |
53,157
-28
| -0.1% | -$4.14K | 4.01% | 6 |
|
|
2020
Q2 | $7.48M | Sell |
53,185
-1,039
| -2% | -$151K | 4.14% | 5 |
|
|
2020
Q1 | $7.11M | Sell |
54,224
-1,000
| -2% | -$142K | 4.55% | 4 |
|
|
2019
Q4 | $8.05M | Sell |
55,224
-4,380
| -7% | -$594K | 3.94% | 5 |
|
|
2019
Q3 | $7.71M | Buy |
59,604
+888
| +2% | +$117K | 3.85% | 6 |
|
|
2019
Q2 | $8.18M | Sell |
58,716
-410
| -0.7% | -$56.8K | 4.14% | 4 |
|
|
2019
Q1 | $8.27M | Sell |
59,126
-348
| -0.6% | -$46.6K | 4.34% | 4 |
|
|
2018
Q4 | $7.67M | Sell |
59,474
-1,511
| -2% | -$211K | 4.38% | 3 |
|
|
2018
Q3 | $8.43M | Buy |
60,985
+512
| +0.8% | +$68K | 4.4% | 2 |
|
|
2018
Q2 | $7.34M | Buy |
60,473
+830
| +1% | +$104K | 4% | 6 |
|
|
2018
Q1 | $7.64M | Sell |
59,643
-4,848
| -8% | -$655K | 4.25% | 3 |
|
|
2017
Q4 | $9.01M | Sell |
64,491
-3,868
| -6% | -$539K | 4.61% | 2 |
|
|
2017
Q3 | $8.89M | Buy |
68,359
+778
| +1% | +$103K | 4.7% | 3 |
|
|
2017
Q2 | $8.94M | Sell |
67,581
-561
| -0.8% | -$71.6K | 5.08% | 3 |
|
|
2017
Q1 | $8.49M | Buy |
68,142
+1,352
| +2% | +$162K | 4.91% | 3 |
|
|
2016
Q4 | $7.7M | Sell |
66,790
-1,010
| -1% | -$117K | 4.62% | 4 |
|
|
2016
Q3 | $8.01M | Sell |
67,800
-5,556
| -8% | -$674K | 4.91% | 4 |
|
|
2016
Q2 | $8.9M | Sell |
73,356
-4,647
| -6% | -$528K | 5.87% | 1 |
|
|
2016
Q1 | $8.44M | Sell |
78,003
-2,934
| -4% | -$304K | 5.83% | 1 |
|
|
2015
Q4 | $8.31M | Sell |
80,937
-6,410
| -7% | -$645K | 5.88% | 1 |
|
|
2015
Q3 | $8.15M | Buy |
87,347
+6,325
| +8% | +$612K | 6.61% | 1 |
|
|
2015
Q2 | $7.9M | Buy |
81,022
+4,250
| +6% | +$426K | 5.97% | 4 |
|
|
2015
Q1 | $7.72M | Sell |
76,772
-1,050
| -1% | -$107K | 5.36% | 3 |
|
|
2014
Q4 | $8.14M | Buy |
77,822
+5,540
| +8% | +$584K | 5.74% | 2 |
|
|
2014
Q3 | $7.71M | Sell |
72,282
-100
| -0.1% | -$10.4K | 6% | 3 |
|
|
2014
Q2 | $7.57M | Sell |
72,382
-100
| -0.1% | -$10.1K | 5.95% | 3 |
|
|
2014
Q1 | $7.12M | Buy |
72,482
+2,460
| +4% | +$228K | 5.65% | 2 |
|
|
2013
Q4 | $6.41M | Buy |
+70,022
| New | +$6.45M | 5.3% | 4 |
|
Other funds holding JNJ
AACR
Blume Capital Management's JNJ Position: Q2 2026 in Review
Blume Capital Management reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $1.77M and leaving 45,083 shares worth $11.4M. The position accounts for 1.67% of the portfolio, ranked #19.
Blume Capital Management first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. The position peaked at $13.8M in Q4 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Blume Capital Management held 45,083 shares of Johnson & Johnson worth $11.4M as of Q2 2026.
- Blume Capital Management sold 7,611 Johnson & Johnson shares in Q2 2026, an estimated $1.77M.
- Johnson & Johnson made up 1.67% of Blume Capital Management's portfolio in Q2 2026, its #19 holding.
- Blume Capital Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
- Blume Capital Management's Johnson & Johnson position peaked at $13.8M in Q4 2025.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.